Noninvasive ventilation with vs without early surfactant to prevent chronic lung disease in preterm infants: A systematic review and meta-analysis

JAMA Pediatrics

Volumn 169, Issue 8, 2015, Pages 731-739

  Isayama, Tetsuya ^a,b   Chai Adisaksopha, Chatree ^a   McDonald, Sarah D ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SURFACTANT; LUNG SURFACTANT;

ARTICLE; BRAIN HEMORRHAGE; CHRONIC LUNG DISEASE; CONTROLLED CLINICAL TRIAL (TOPIC); DEATH; DEVELOPMENTAL DISORDER; EXTUBATION; HUMAN; INTUBATE SURFACTANT EXTUBATE; META ANALYSIS; NERVE CELL DIFFERENTIATION; NONINVASIVE CONTINUOUS POSITIVE AIRWAY PRESSURE; NONINVASIVE VENTILATION; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; SYSTEMATIC REVIEW; CATHETERIZATION; CEREBRAL HEMORRHAGE; CHRONIC DISEASE; COMPLICATION; ENDOTRACHEAL INTUBATION; FEMALE; LUNG DYSPLASIA; LUNG INJURY; MALE; MORTALITY; NEWBORN; PNEUMOTHORAX; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

BRONCHOPULMONARY DYSPLASIA; CATHETERIZATION; CEREBRAL HEMORRHAGE; CHRONIC DISEASE; FEMALE; HUMANS; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INTUBATION, INTRATRACHEAL; LUNG INJURY; MALE; PNEUMOTHORAX; POSITIVE-PRESSURE RESPIRATION; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 84939813402     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2015.0510     Document Type: Article

References (39)

1. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7): 1723-1729.
2. Van Marter LJ. Epidemiology of bronchopulmonary dysplasia. Semin Fetal Neonatal Med. 2009;14(6):358-366.
3. Horbar JD, Carpenter JH, Badger GJ, et al. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics. 2012;129(6):1019-1026.
4. Yoder BA, Harrison M, Clark RH. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants. Pediatrics. 2009;124 (2):673-679.
5. Canadian Neonatal Network (CNN) Annual Report 2011. http://www.canadianneonatalnetwork.org/Portal/LinkClick.aspx?fileticket=rCVwkKlA4pc%3d&tabid=39. Accessed August 24, 2014.
6. Sweet DG, Carnielli V, Greisen G, et al European Association of Perinatal Medicine. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants: 2013 update. Neonatology. 2013;103(4): 353-368.
7. Schmölzer GM, Kumar M, Pichler G, Aziz K, O'Reilly M, Cheung PY. Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis. BMJ.2013; 347:f5980.
8. Rojas-Reyes MX, Morley CJ, Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2012;3:CD000510.
9. Fischer HS, Bührer C. Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a meta-analysis. Pediatrics. 2013;132(5):e1351-e1360.
10. Polin RA, Carlo WA; Committee on Fetus and Newborn; American Academy of Pediatrics. Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatrics. 2014;133(1):156-163.
11. Engle WA; American Academy of Pediatrics Committee on Fetus and Newborn. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics. 2008;121(2):419-432.
12. Sweet DG, Carnielli V, Greisen G, et al European Association of Perinatal Medicine. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants - 2010 update. Neonatology. 2010;97(4):402-417.
13. Pfister RH, Soll RF. Initial respiratory support of preterm infants: the role of CPAP, the INSURE method, and noninvasive ventilation. Clin Perinatol. 2012;39(3):459-481.
14. Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2012;11:CD001456.
15. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. Oxford, England: Cochrane Collaboration; 2011. handbook.cochrane.org.
16. Guyatt GH, Oxman AD, Vist GE, et al GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926.
17. Mazela J, Merritt TA, Finer NN. Aerosolized surfactants.Curr Opin Pediatr. 2007;19(2):155-162.
18. Göpel W, Kribs A, Ziegler A, et al German Neonatal Network. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet. 2011;378(9803):1627-1634.
19. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978; 92(4):529-534.
20. A Service of the US National Institutes of Health. ClinicalTrials.gov. clinicaltrials.gov/ct2/home. Accessed February 1, 2014.
21. World Health Organization. International Clinical Trials Registry Platform (ICTRP). 2014. http://www.who.int/ictrp/about/en/. Accessed January 26, 2014.
22. Cornell JE, Mulrow CD, Localio R, et al. Random-effects meta-analysis of inconsistent effects: a time for change. Ann Intern Med.2014;160(4):267-270.
23. Viechtbauer W. Conducting meta-analyses in R with the Metafor package. JStatSoftw. 2010;36(3): 1-48.
24. Guyatt GH, Oxman AD, Santesso N, et al. GRADE guidelines, 12: preparing summary of findings tables-binary outcomes. J Clin Epidemiol. 2013;66(2):158-172.
25. Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines, 3: rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401-406.
26. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines 6. Rating the quality of evidence--imprecision. J Clin Epidemiol. 2011;64 (12):1283-1293.
27. Dilmen U, Özdemir R, Tatar Aksoy H, et al. Early regular versus late selective poractant treatment in preterm infants born between 25 and 30 gestational weeks: a prospective randomized multicenter study. J Matern Fetal Neonatal Med. 2014;27(4):411-415.
28. Dunn MS, Kaempf J, de Klerk A, et al Vermont Oxford Network DRM Study Group. Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics. 2011;128(5):e1069-e1076.
29. Imani M, Derafshi R, Khalili M, Arbabisarjou A. Comparison of nasal continuous positive airway pressure therapy with and without prophylactic surfactant in preterm neonates. Iranian J Neonatol. 2013;4(3):26-34.
30. Kandraju H, Murki S, Subramanian S, Gaddam P, Deorari A, Kumar P. Early routine versus late selective surfactant in preterm neonates with respiratory distress syndrome on nasal continuous positive airway pressure: a randomized controlled trial. Neonatology. 2013;103(2):148-154.
31. Reininger A, Khalak R, Kendig JW, et al. Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial. J Perinatol. 2005;25(11):703-708.
32. Rojas MA, Lozano JM, Rojas MX, et al Colombian Neonatal Research Network. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Pediatrics. 2009;123(1):137-142.
33. Sandri F, Plavka R, Ancora G, et al CURPAP Study Group. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics. 2010;125(6):e1402-e1409.
34. Verder H, Robertson B, Greisen G, et al Danish-Swedish Multicenter Study Group. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. N Engl J Med. 1994;331(16): 1051-1055.
35. Verder H, Albertsen P, Ebbesen F, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation.Pediatrics. 1999;103(2):E24.
36. Walsh MC, Yao Q, Gettner P, et al National Institute of Child Health and Human Development Neonatal Research Network. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 2004;114(5):1305-1311.
37. Guyatt GH, Briel M, Glasziou P, Bassler D, Montori VM. Problems of stopping trials early. BMJ. 2012;344:e3863.
38. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines, 1: introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383-394.
39. Stevens TP, Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev. 2007;(4):CD003063.